Clinical Importance of S100A9 in Osteosarcoma Development and as a Diagnostic Marker and Therapeutic Target

Bioengineered - United Kingdom
doi 10.1080/21655979.2019.1607709
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Plasticity of Th17 and Tregs and Its Clinical Importance as Therapeutic Target in Inflammatory Bowel Disease

Indian Journal of Inflammation Research
2018English

Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma

Oncotarget
Oncology
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

SLAMF7 (CD319/CS1) Is Expressed in Plasmablastic Lymphoma and Is a Potential Diagnostic Marker and Therapeutic Target

British Journal of Haematology
Hematology
2018English

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Stem Cells International
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy